Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesco Schietroma
Observed name:
F. Schietroma
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Azienda Sanitaria Locale Viterbo,
Ospedale di Belcolle,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Azienda Sanitaria Locale Viterbo,
Ospedale di Belcolle,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0009-9669-8602
Observed ORCID:
0009-0009-9669-8602
OpenAlex ID:
A5059593129
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
2022
·
Alessio Stefani
, Geny Piro
, et al.
·
Frontiers in Oncology
·
18
PDF
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study
2025
·
Carlo Signorelli
, Michele Basso
, et al.
·
Cancers
·
6
PDF
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis
2024
·
Michele Basso
, Carlo Signorelli
, et al.
·
Targeted Oncology
·
6
PDF
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study
2025
·
Carlo Signorelli
, Maria Alessandra Calegari
, et al.
·
Cancers
·
5
PDF
Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis
2024
·
Francesco Schietroma
, Annunziato Anghelone
, et al.
·
Cancers
·
5
PDF
The impact of the multidisciplinary team (MDT) in the management of colorectal cancer (CRC).
2022
·
Annunziato Anghelone
, Maria Bensi
, et al.
·
Journal of Clinical Oncology
·
5
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset
2025
·
V. Daprà
, A. Gandini
, et al.
·
ESMO Open
·
4
PDF
Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study.
2023
·
Federica Marmorino
, Gianmarco Piccinno
, et al.
·
Journal of Clinical Oncology
·
4
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC)
2025
·
Francesco Schietroma
, Maria Bensi
, et al.
·
Clinical Colorectal Cancer
·
3
Fertility and sexuality in early-onset colorectal cancer patients: a monocentric survey
2025
·
A. Spring
, M.A. Calegari
, et al.
·
ESMO Gastrointestinal Oncology
·
2
PDF
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic
2024
·
Alessandro Parisi
, Riccardo Giampieri
, et al.
·
The Oncologist
·
2
SO-22 Gut microbiome composition as predictor of the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the AtezoTRIBE study
2023
·
F. Marmorino
, G. Piccinno
, et al.
·
Annals of Oncology
·
2
PDF
Long-term survival and prognostic factors after repeated metastasectomies in metastatic colorectal cancer: a 15-years retrospective study
2025
·
Giovanni Trovato
, Francesco Schietroma
, et al.
·
The Oncologist
·
1
Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study
2025
·
Fabrizio Nelli
, Enzo Maria Ruggeri
, et al.
·
Vaccines
·
1
PDF
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort
2025
·
Jessica Lucchetti
, Lorenzo Angotti
, et al.
·
Clinical Colorectal Cancer
·
1
PDF
55P Combining systemic treatments and multiple surgical resections in oligometastatic colorectal cancer patients: A referral center experience
2025
·
G. Trovato
, F. Schietroma
, et al.
·
Annals of Oncology
PDF
587P Homologous recombination (HR) and DNA damage repair (DDR) somatic alterations in metastatic colorectal cancer (mCRC): Results from the comprehensive genomic profiling (CGP) trial FPG500
2024
·
F. Schietroma
, G. Caira
, et al.
·
Annals of Oncology
Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.
2024
·
Alberto Puccini
, Daniele Rossini
, et al.
·
Journal of Clinical Oncology
136P Fertility and sexuality in early onset-colorectal cancer (EO-CRC) patients (pts): A monocentric survey
2024
·
A. Spring
, D. Barone
, et al.
·
Annals of Oncology
PDF
112P The presence of liver metastases does not predict resistance to immunotherapy in proficient MMR metastatic colorectal cancer (mCRC): A secondary analysis of the AtezoTRIBE study
2024
·
M. Carullo
, C. Antoniotti
, et al.
·
Annals of Oncology
PDF
18P Clinical outcomes in pT4N0 colon cancer (CC) patients: Data from a large, multicenter, real-word cohort
2024
·
V. Daprà
, D. Rossini
, et al.
·
Annals of Oncology
PDF
648P Medium to long-term effects of the COVID-19 pandemic on colorectal cancer diagnosis and management in Italy: Preliminary findings from an updated analysis of the real-world multicenter COVID-DELAY study
2023
·
A. Parisi
, F. Gelsomino
, et al.
·
Annals of Oncology
PDF
1679P Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis
2023
·
L. Mastrantoni
, V. Beccia
, et al.
·
Annals of Oncology
PDF
571P Artificial intelligence-powered analysis of tumor lymphocytes infiltration: A translational analysis of AtezoTRIBE trial
2023
·
M. Carullo
, C. Antoniotti
, et al.
·
Annals of Oncology
PDF
Management of Early-onset Metastatic Colorectal Cancer (ERMIONE): A single institution analysis.
2023
·
Giustina Valente
, Armando Di Bello
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
35
Citation count:
65
H-index:
5
I10-index:
1
Year
Topic
Type